The high prevalence of DUOX2 variant in our work is consistent with previous studies in China (variant rate of DUOX2 from 31.8 to 62.5%), suggesting that DUOX2 is an important causative gene involved in the pathogenesis of CH (31–33). The gene discussed is DUOX2; the disease is cyclic hematopoiesis.